2-Methyl-2,4,5,6-tetrahydrocyclopenta[c]pyrazole-3-carboxylic acid, 95.0%, 250mg

4-(2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine, 95.0%, 1g

3-Ethynylpyridin-2-amine, 97.0%, 250mg

{[(4-chlorophenyl)methyl]sulfanyl}methanimidamide hydrobromide, 95.0%, 1g

1-Bromo-4-methoxynaphthalene, 95.0%, 25g

H-Arg-OMe 2HCl, 97.00%, 10g

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-(2-hydroxy-4-methoxybenzyl)glycine, 97%, 5g

4-(Methylamino)-1-(pyridin-3-yl)butan-1-one dihydrochloride, 97%, 100mg

2-(Methacryloyloxy)ethyl 3-oxobutanoate (stabilised with BHT), 95.0%, 500g

5-(2,4-Difluorophenyl)-1,3,4-oxadiazol-2-amine, 95%, 100mg

(S)-5-(((tert-Butyldimethylsilyl)oxy)methyl)-1-(5-methoxy-2-nitro-4-((triisopropylsilyl)oxy)benzoyl)pyrrolidin-3-one, 100mg

1-(4-Methoxy-phenyl)-5-methyl-1H-pyrazole-4-carbonyl chloride, 1g

tert-Butyl (4-ethynylphenyl)carbamate, 97%, 1g